# Inhibition of type I interferon signaling is a conserved function of gamma-herpesvirus-encoded microRNAs

**Authors:** Devin N. Fachko, Yan Chen, Nikita S. Ivanov, Bonnie Goff, Brian Pendergrass, Darby G. Oldenburg, Ryan D. Estep, Scott W. Wong, Rebecca L. Skalsky

PMC · DOI: 10.1128/jvi.01579-25 · Journal of Virology · 2025-12-31

## TL;DR

This paper shows that gamma-herpesviruses use microRNAs to suppress interferon signaling, a key immune response, to persist in their hosts.

## Contribution

The study reveals that miRNAs from non-human primate gamma-herpesviruses inhibit type I interferon signaling, a conserved antiviral evasion strategy.

## Key findings

- Multiple viral miRNAs reduce IFN-stimulated gene expression in primary cells.
- Viral miRNAs target IFN receptors and JAK/STAT pathway components.
- Infection with miRNA-deficient viruses increases sensitivity to interferon.

## Abstract

Herpesviruses encode multiple factors that disarm innate immune signaling to evade host anti-viral responses. Several viral microRNAs expressed by Epstein-Barr virus (EBV) and Kaposi’s sarcoma-associated herpesvirus (KSHV) disrupt the induction of type I interferons (IFN) and/or the subsequent signaling events activated through type I IFN receptors. Here, we aimed to determine whether non-human primate (NHP) γ-herpesviruses (rhesus lymphocryptovirus [rLCV], rhesus rhadinovirus [RRV], and Japanese macaque rhadinovirus [JMRV]), closely related to EBV and KSHV, use similar microRNA (miRNA)-mediated strategies to regulate IFN responses. Through functional screens, we identified multiple viral miRNAs that attenuated type I IFN-mediated activation of an IFN-stimulated response element reporter and diminished expression of interferon-stimulated genes (ISGs). Infection of primary cells with miRNA-deficient rLCVs resulted in augmented expression of ISGs. Abrogation of EBV BART miRNA homologs from rLCV, in particular, led to heightened sensitivity of latently infected cells to exogenous type I IFN. Through sequence analysis and reporter assays, we show that targets of these viral miRNAs include transcripts encoding the type I IFN receptors (IFNAR1, IFNAR2) and core components of JAK/STAT signaling pathways (JAK1, IRF9). Taken together, these data demonstrate that suppression of type I IFN responses is a conserved function for NHP γ-herpesvirus miRNAs and provide important mechanistic insight into how these viral miRNAs regulate type I IFN signaling pathways.

Gamma-herpesviruses establish life-long infections in their hosts. Evading anti-viral responses is a key component of long-term viral persistence. In this work, we show that small noncoding RNAs expressed by multiple non-human primate γ-herpesviruses regulate anti-viral responses by directly targeting components of the type I interferon (IFN) signaling pathway.

## Linked entities

- **Genes:** IFNAR1 (interferon alpha and beta receptor subunit 1) [NCBI Gene 3454], IFNAR2 (interferon alpha and beta receptor subunit 2) [NCBI Gene 3455], JAK1 (Janus kinase 1) [NCBI Gene 3716], IRF9 (interferon regulatory factor 9) [NCBI Gene 10379]

## Full-text entities

- **Genes:** IFNA1 (interferon alpha 1) [NCBI Gene 3439] {aka IFL, IFN, IFN-ALPHA, IFN-alphaD, IFNA13, IFNA@}, JAK1 (Janus kinase 1) [NCBI Gene 3716] {aka AIIDE, JAK1A, JAK1B, JTK3}, IFNAR1 (interferon alpha and beta receptor subunit 1) [NCBI Gene 3454] {aka AVP, CRF2-1, IFN-R-1, IFN-alpha-REC, IFNAR, IFNBR}, IFNAR2 (interferon alpha and beta receptor subunit 2) [NCBI Gene 3455] {aka IFN-R, IFN-R-2, IFN-alpha-REC, IFNABR, IFNARB, IMD45}, IRF9 (interferon regulatory factor 9) [NCBI Gene 10379] {aka IRF-9, ISGF3, ISGF3G, p48}
- **Species:** Macacine gammaherpesvirus 5 (Rhesus rhadinovirus, no rank) [taxon 154334], Human gammaherpesvirus 8 (no rank) [taxon 37296], Homo sapiens (human, species) [taxon 9606], human gammaherpesvirus 4 (Epstein Barr virus, no rank) [taxon 10376], Macacine gammaherpesvirus 4 (Rhesus lymphocryptovirus, no rank) [taxon 45455]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12911870/full.md

## Figures

7 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12911870/full.md

## References

57 references — full list in the complete paper: https://tomesphere.com/paper/PMC12911870/full.md

---
Source: https://tomesphere.com/paper/PMC12911870